Leonteq Securities Ag (Q00135) News

BAER: Do NOT toss this post across iHub, StockTwits, X, nor anyplace else, Bro!! I get up today MONSTER-early to work Wall Street, but NO stocks data is being displayed on my machines!!! So, I PANIC like a Forest Gump, Downs Syndrome, MONGOLOID IDIOT, for 15-minutes!!! Finally, I ask COPILOT , "Is

Mm ASCM has a size short position and MMS aiding in trying to cover. Dips won't help much either given the buy interests and tight float. This is classic high beta volatility, and the moves that come with it. Nobody's selling in size and they'll lose inventories dropping it IMO. Holding on and pati

Democrats Face Defining Moment Over Laken Riley Act

So many ways to fail, and few ways to win.

by Mark Angelides | Jan 9, 2025


On Tuesday, January 7, the House passed the Laken Riley Act – a short bill that seeks to require the detention of any i

There is confusion here between a scientific publication passing peer review and regulatory approval, they are not equivalent. Peer review is not implying or equating to regulatory approval.

For one the peer review scientists, as apposed to the regulatory agency e.g. EMA, will not ha

SCAM

He has made claims that he is holding shares but lately is only negative on this board. You have to wonder if these people have any understanding of their behavior and how transparent it is.

Here's what investors will be looking for in the OLE slides: two graphs. Each graph will chart the endpoints (Cog13 and ADL) from week 0 to 192 and have two lines: 'early' and 'delayed start'.

Particular investor focus will be on the ADL graph. If it shows clear absolute shallowing of

How much for the bridge?

Awesome! We will keep going working to make this app better for all of us. About that specific issue, I couldn't reproduce but our dev team is aware about it, we will investigate further. Please, other bugs or feedbacks you think is relevant, let me know. Thank you.

oh course JAMA means approval....--noted. LMFAO.

Come back at me with this JAMA when this is rejected.

style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: arial, helvetica, sans-serif"Third Quarter 2024 Results
style="caret-color: rgb(33, 37, 41); color: rgb

New Year but same old Veri. Probably didn't even know markets were closed today. No wonder revenues on the decline

Don't 'back pedal'. Just use your head. Start now.
(Btw how many minutes do we have at the conf? Again: the head.)

He's just been using other aliases. I told the board yesterday about how a month or so ago he had an extensive reply to a "question" posed by a user (that wasn't him 😂😂) and they deleted it. He replied to this user in less than two minutes with an extensive reply that had to have bee

New Poll Clarifies Where the Two Big Parties Stand

Political strategists are bound to have fun with this one.

by Leesa K. Donner | Jan 9, 2025

Now that the dust has settled, and Vice President Kamala Harris has certified the 2024 election, Democrats and R

New new news release.

They keep saying IPO. I’m sure they know the difference between an IPO and an SPO, no?
The IPO could be in reference to CSS.

Bill Ackman will be getting a seat in the new public company ( CSS ) and in FNMA like he does with most of his large public company investments.

I'm glad you have finally admitted to being a manipulating short in sheep's clothing. Now we know to ignore your dishonest posts.

Keep flooding the board with your verbal diarrhea 

I’m not sure “the shit” is something I’d want to eat. Why has that phrase become so widespread?

The Orange Embecile Strikes Again

As wildfires ravaged Los Angeles County, a clip from Joe Rogan's podcast featuring President-elect Donald Trump resurfaced on social media. In the episode, recorded weeks before the election, Rogan and Trump discussed the possibility of a major wildfi

Not according to Jama. And with no due respect, your opinion isn't even worth the paper jama is published on. You are an anonymous manipulating short whereas jama is a world renowned medical journal.

Have a not nice day

Agree - along with the Timo Grimmer OLE abstract. Together they are extremely compelling and what the EMA and FDA will consider.

on LWLG Revenues mix from the May 2024 ASM and I would not expect this to have changed

What will come first, licensing our product revenue and which to expect to drive Company revenue?

Clearly, we expect licensed materials initially, then followed by product revenue. W

Shear stupidity-

https://media.gettr.com/group6/getter/2025/01/08/23/f88c57fe-a00e-552d-b502-8e35a20f0e06/9e0875e6c2973511213e84bf88a160eb_768x0.jpg